Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00637000Phase 2Completed
A Phase 2 trial of buprenorphine, naloxone in opioid use disorder (OUD), sponsored by Indivior. Started Mar 2008; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00637000.